Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-623-0 | CAS number: 123-38-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 993
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- only 1000 instead of 2000 immature erythrocytes per animal were scored
- GLP compliance:
- yes
- Remarks:
- Bushy Run Research Center
- Type of assay:
- micronucleus assay
Test material
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): propionaldehyde
- Physical state: water white liquid
- Analytical purity: approximately 98%
- Storage condition of test material: room temperature under nitrogen
Test animals
- Species:
- mouse
- Strain:
- Swiss Webster
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, (Portage, MI, USA)
- Age at study initiation: approximately 5 weeks
- Weight at study initiation: 23.3 to 27.3 g for males and 18.4 to 22.0 g for females
- Assigned to test groups randomly: yes, under following basis: nonstratified randomization procedure based on body weight
- Housing: group housed
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-26
- Humidity (%): 40-70
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 1992-03-30 To: 1992-04-09
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used:sterile, distilled, deionized water
- Concentration of test material in vehicle: no data
- Positive control was diluted first in ethanol then in sterile, distilled, deionized water - Details on exposure:
- Animals were given 240, 480 or 768 mg/kg of propionaldehyde as a single intraperitoneal injection. Injection volumes for all animals were based on
individual body weights determined the day before dosing. Bone marrow was collected 12, 24, and 48 hours after treatment with the test substance.
Vehicle control and positive control were given as a single intraperitoneal injection. Bone marrow was collected 24 hours later. - Duration of treatment / exposure:
- 12, 24, 48 hours
- Frequency of treatment:
- single injection
- Post exposure period:
- none
Doses / concentrationsopen allclose all
- Dose / conc.:
- 240 mg/kg bw/day (nominal)
- Dose / conc.:
- 480 mg/kg bw/day (nominal)
- Dose / conc.:
- 768 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5/sex for control groups
15/sex for propionaldehyde groups (5/sex for each time point of bone marrow preparation) - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- triethylenemelamine
- Route of administration: intraperitoneal
- Doses / concentrations: 3 mg/kg
Examinations
- Tissues and cell types examined:
- bone marrow, polychromatic erythrocytes (PCE), normochromatic erythrocytes (NCE)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: 25%, 50%, and 80% of LD50
DETAILS OF SLIDE PREPARATION: a drop of the bone marrow cell suspension was smeared on a microscopic slide. Slides were stained with Gurr's R-66 Giemsa diluted in phosphate buffer.
METHOD OF ANALYSIS: Slides were coded with the randomly-assigned animal numbers and read without knowledge of treatment group to prevent bias. The PCE:NCE ratio for a total of 1000 celle for each animal was calculated to provide an estimate of propionaldehyde cytotoxicity. A minimum of 1000 PCE for each animal was scored for the presence of micronuclei unless the cytotoxicity of the test substance prevented this. - Evaluation criteria:
- The PCE:NCE ratio for approximately 1000 total cells will be calculated, recorded, and shown in the final report to provide an estimate of the cytotoxicity of the test agent. Excessive cytotoxicity in this test system will be defined by a PCE:NCE ratio of 0.10 or lower. Animals with an excessive reduction in the PCE:NCE ratio will be identified in the raw data and final report but micronuclei will not be scored. A minimum of 1000 PCE per animal will be scored for the presence of micronuclei unless the cytotoxicity of the test substance prevents this.
- Statistics:
- Data were statistically evaluated using the Mann-Whitney U test. All statistical analyses were performed using BMDP Statistical Software (Dixon, 1990). For all statistical tests, the probability value of < 0.05 (two-tailed) was used as the critical level of significance.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- at 768 mg/kg bw.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
LD50 = 961 mg/kg bw. (95% confidence interval, 836 to 1104 mg/kg) for the combined sexes. At 667 mg/kg, the highest dose with 3 or more survivors of each sex, the proportion of PCE was 67% of the vehicle control value for the male mice and 92% for the female mice. Based upon the results of the range-finding study, the dose levels for the definitive study were set at 25%, 50% and 80% of the LD50 or 240, 480, and 768 mg/kg propionaldehyde.
RESULTS OF DEFINITIVE STUDY
There was a statistically significant decrease (57.9% of control, p < 0.01) in the PCE to NCE ratio at the 48 hour sampling time among female mice treated with 768 mg/kg propionaldehyde. There was also a decrease (79.3% of control) in the PCE to NCE ratio among male mice treated with propionaldehyde, but it was not statistically significant. Statistically significant increases in the PCE to NCE ratios were also observed in propionaldehyde-treated mice of both sexes. However, those increased ratios were within normal ranges and were not considered biologically significant.
Results micronucleated PCE: see table 1.
Clinical observations for the micronucleus assay:
There were no signs of toxicity in male or female mice in the 240 mg/kg group or in females in the 480 mg/kg group. Among the males in the 480 mg/kg group, lethargy, rapid breathing and unkempt appearance were observed after dosing, but no signs of toxicity except unkempt appearance persisted beyond the postdosing period. Toxic signs including gasping, prostration, and rapid breathing were observed in males and females in the 768 mg/kg group immediately after dosing, but did not persist. In the 768 mg/kg group, toxic signs during Days 2 and 3 were limited to unkempt appearance, except that 1 female was also prostrate and 1 male died on Day 3.
Any other information on results incl. tables
Table 1:
# PCE observed | # PCE with MN | % PCE with MN | ||
Dose (mg/kg) | Sex | 12-hour sample | ||
240 | M | 5000 | 3 | 0.06 |
F | 5000 | 4 | 0.08 | |
480 | M | 5000 | 1 | 0.02 |
F | 5000 | 7 | 0.14 | |
768 | M | 5000 | 2 | 0.04 |
F | 5000 | 2 | 0.04 | |
24-hour sample | ||||
water | M | 5000 | 2 | 0.04 |
F | 5000 | 7 | 0.14 | |
240 | M | 5000 | 3 | 0.06 |
F | 5000 | 4 | 0.08 | |
480 | M | 5000 | 9 | 0.18 |
F | 5000 | 2 | 0.04 | |
768 | M | 5000 | 9 | 0.18* |
F | 5000 | 2 | 0.04 | |
TEM (positive control) | M | 5000 | 92 | 1.84*** |
F | 5000 | 56 | 1.12*** | |
48-hours sample | ||||
240 | M | 5000 | 6 | 0.12 |
F | 5000 | 1 | 0.02 | |
480 | M | 5000 | 4 | 0.08 |
F | 5000 | 6 | 0.12 | |
768 | M | 4000 | 9 | 0.22* |
F | 5000 | 4 | 0.08 |
*: p< 0.05; *** p< 0.01
Although the incidence of micronucleated PCE was statistically significant among high dose males at both the 24 and 48 hour sacrifices, propionaldehyde was not considered to be an inducer of micronuclei in male mice for the following reasons. First, the incidence of micronucleated PCE was low in the vehicle control males as compared to the vehicle control females. Although the frequency of micronucleated PCE in the vehicle control males is within a normal range, it is at the low end of the range. The high dose male mice had a high incidence of micronucleated PCE as compared to the male vehicle control, but both the overall incidences of micronucleated PCE and the distribution of micronucleated PCE in each animal were within normal ranges. Furthermore, there was no consistent relationship between increasing propionaldehyde dose and increasing incidence of micronucleated PCE among either male or female mice.
Applicant's summary and conclusion
- Conclusions:
- Propionaldehyde did not produce biologically significant or dose-related increases in the frequency of micronucleated polychromatic erythrocytes in the bone marrow of male or female Swiss-Webster mice assessed at 12, 24, or 48 hours after treatment with a single dose by intraperitoneal injection. Therefore, propionaldehyde was not considered to be an inducer of micronuclei under the conditions of this in vivo assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.